Reply to: "Comment on 'Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis'"

1 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Journal of the American Academy of Dermatology
Vol/bind	85
Udgave nummer	6
Sider (fra-til)	e379
ISSN	0190-9622
DOI	https://doi.org/10.1016/j.jaad.2019.05.082
Status	Udgivet - dec. 2021

Adgang til dokumentet

@article{1756fe7e86af40c0b4fdf73fcf699c92,

title = "Reply to: {"}Comment on 'Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis'{"}",

keywords = "Antibodies, Monoclonal, Humanized, Humans, Pharmaceutical Preparations, Psoriasis/drug therapy",

author = "Alexander Egeberg and Bryld, {Lars Erik} and Lone Skov",

year = "2021",

month = dec,

doi = "10.1016/j.jaad.2019.05.082",

language = "English",

volume = "85",

pages = "e379",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - Reply to: "Comment on 'Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis'"

AU - Egeberg, Alexander

AU - Bryld, Lars Erik

AU - Skov, Lone

PY - 2021/12

Y1 - 2021/12

KW - Antibodies, Monoclonal, Humanized

KW - Humans

KW - Pharmaceutical Preparations

KW - Psoriasis/drug therapy

UR - http://www.scopus.com/inward/record.url?scp=85078728283&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2019.05.082

DO - 10.1016/j.jaad.2019.05.082

M3 - Letter

C2 - 31170436

SN - 0190-9622

VL - 85

SP - e379

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 6

ER -